Register entryRepackager / relabeller

scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation

Data as of · How to read this entry

Registered sites
1
Active NDC listings
2
Live patents
0
Countries
1
Base
United States
Authorisation

Registered operations

Labelling1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
scPharmaceuticals Inc.Registrant: scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation25 Mall Road, Suite 203, Burligton, Massachusetts (MA) 01803, United States (USA)Labelling, Packaging3013722099079386513
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.

Dosage formNDCs
injection2
RouteNDCs
subcutaneous2
Labeller name on the listingNDCs
scpharmaceuticals inc., a wholly owned subsidiary of mannkind corporation2
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
FUROSCIXfurosemide injection 80 mg/ 10 mLinjection, subcutaneous71767-100NDA
FUROSCIXfurosemideinjection, subcutaneous71767-111NDA
Compare

Comparable companies in United States

Enquiry

Common questions

Is scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation FDA approved?
scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation holds 1 FDA-registered establishment in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation's registered sites?
The FDA register lists Burligton, MA. Registered operations: labelling, packaging.
What drugs does scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation make?
2 products are listed under scPharmaceuticals Inc., a wholly owned subsidiary of MannKind Corporation in the openFDA NDC Directory, most often as injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.